Medicare Enrolled
Dr. Pramthesh Desai, MD
Pulmonary Disease · Wilkes Barre, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Desai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Desai?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Desai
Dr. Pramthesh Desai is a pulmonary disease specialist in Wilkes Barre, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Desai performed 5,160 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Desai received a total of $77,712 from 48 pharmaceutical and/or device companies across 1091 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Desai is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 1% volume in PA
$77,712 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,160
Medicare services
Top 1% in PA for pulmonary disease
Not available
Unique patients (not deduplicated)
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
1,865 | $38 | $75 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,094 | $60 | $110 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
376 | $88 | $145 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
302 | $99 | $180 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
235 | $6 | $30 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
225 | $8 | $30 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
205 | $7 | $65 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
184 | $63 | $125 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
176 | $91 | $155 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
147 | $113 | $180 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
81 | $31 | $250 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
77 | $82 | $350 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
50 | $133 | $225 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
33 | $6 | $90 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
32 | $36 | $319 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
25 | $75 | $165 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
23 | $31 | $100 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
17 | $64 | $135 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
13 | $83 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$77,712
Total received (2018-2024)
Avg $11,102/year across 7 years
Top 6% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
1,091
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,614
2023
$6,862
2022
$8,437
2021
$16,027
2020
$9,836
2019
$12,501
2018
$20,436
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$1,321
GlaxoSmithKline, LLC.
$472
Boehringer Ingelheim Pharmaceuticals, Inc.
$272
Regeneron Healthcare Solutions, Inc.
$210
GENZYME CORPORATION
$183
Mylan Specialty L.P.
$182
Philips North America LLC
$159
Mallinckrodt Hospital Products Inc.
$134
Vifor Pharma, Inc.
$125
ABBVIE INC.
$98
SANOFI-AVENTIS U.S. LLC
$90
Paratek Pharmaceuticals, Inc.
$73
PFIZER INC.
$51
Takeda Pharmaceuticals U.S.A., Inc.
$43
Amgen Inc.
$36
Grifols USA, LLC
$36
Electromed, Inc.
$23
Insmed, Inc.
$18
Merck Sharp & Dohme LLC
$16
Actelion Pharmaceuticals US, Inc.
$16
Avadel CNS Pharmaceuticals, LLC
$15
Axsome Therapeutics, Inc.
$15
ANI Pharmaceuticals, Inc.
$14
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$13
Top 3 companies account for 57.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$37,461
Boehringer Ingelheim Pharmaceuticals, Inc.
$14,005
Mylan Specialty L.P.
$9,118
Sunovion Pharmaceuticals Inc.
$5,674
GlaxoSmithKline, LLC.
$2,968
Intuitive Surgical, Inc.
$1,500
Regeneron Healthcare Solutions, Inc.
$1,276
GENZYME CORPORATION
$789
Mallinckrodt Hospital Products Inc.
$659
Grifols USA, LLC
$410
Merck Sharp & Dohme Corporation
$274
PFIZER INC.
$271
Allergan Inc.
$206
Takeda Pharmaceuticals U.S.A., Inc.
$204
Actelion Pharmaceuticals US, Inc.
$201
Circassia Pharmaceuticals Inc
$199
Genentech USA, Inc.
$178
ABBVIE INC.
$161
AbbVie Inc.
$160
Philips North America LLC
$159
Electromed, Inc.
$158
Pulmonx Corporation
$149
Inari Medical, Inc.
$147
SANOFI-AVENTIS U.S. LLC
$136
Philips Electronics North America Corporation
$127
Vifor Pharma, Inc.
$125
E.R. Squibb & Sons, L.L.C.
$113
Paratek Pharmaceuticals, Inc.
$107
Allergan, Inc.
$80
Advanced Respiratory, Inc
$77
Axsome Therapeutics, Inc.
$73
Novartis Pharmaceuticals Corporation
$64
Insmed, Inc.
$62
Janssen Pharmaceuticals, Inc
$62
Merck Sharp & Dohme LLC
$60
Amgen Inc.
$49
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$38
Ambu Inc.
$35
Inogen, Inc.
$31
Vapotherm Inc
$18
Alexion Pharmaceuticals, Inc.
$18
Baxter Healthcare
$18
Mallinckrodt Enterprises LLC
$16
Novo Nordisk Inc
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
Avadel CNS Pharmaceuticals, LLC
$15
ANI Pharmaceuticals, Inc.
$14
Melinta Therapeutics, Inc.
$11
Top 3 companies account for 78.0% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · ASMANEX · AVYCAZ · Adempas · Arikayce · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHANTIX · CHARTIS CATHETER · DALVANCE · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Da Vinci Surgical System · ELIQUIS · Esbriet · FARXIGA · FASENRA · FLOWTRIEVER CATHETER · GLASSIA · Hillrom - Life 2000 Ventilation System · INOGEN ONE G3 OXYGEN CONCENTRATOR · KEYTRUDA · LONHALA MAGNAIR · LUMRYZ · Life 2000 Ventilation System · LifeVest · NEXVIAZYME · NIOX VERO · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Prolastin-C Liquid · S · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Sunosi · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · The Vest System Model 105 Home Care · Tresiba · Trilogy 100 · ULTOMIRIS · UPTRAVI · UTIBRON NEOHALER · Utibron · VAPOTHERM · Vabomere · XARELTO · XOLAIR · Xolair · YUPELRI · Yupelri · ZERBAXA · Zemaira
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
14
County median income
$62,321
Nearest hospital to ZIP centroid (approximate)
GEISINGER BEHAVIORAL HEALTH CENTER NORTHEAST
9.7 mi
9.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Desai is a mixed practice specialist, with above-average Medicare volume (top 1% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Desai experienced with hospital follow-up visit, low complexity?
Based on Medicare claims data, Dr. Desai performed 1,865 hospital follow-up visit, low complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Desai receive payments from pharmaceutical companies?
Yes. Dr. Desai received a total of $77,712 from 48 companies across 1,091 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Desai's costs compare to other pulmonary diseases in Wilkes Barre?
Dr. Desai's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Desai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Wilkes Barre
Browse pulmonary diseases in Wilkes Barre ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in PA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in PA
Which PA pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Mylan Specialty L.P. Payments to Doctors
See all physicians who received payments from Mylan Specialty L.P.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology